2-28412095-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005253.4(FOSL2):c.628C>T(p.Arg210Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000361 in 1,606,164 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )
Consequence
FOSL2
NM_005253.4 missense
NM_005253.4 missense
Scores
1
12
6
Clinical Significance
Conservation
PhyloP100: 5.99
Genes affected
FOSL2 (HGNC:3798): (FOS like 2, AP-1 transcription factor subunit) The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOSL2 | NM_005253.4 | c.628C>T | p.Arg210Cys | missense_variant | 4/4 | ENST00000264716.9 | NP_005244.1 | |
FOSL2 | XM_006711976.4 | c.679C>T | p.Arg227Cys | missense_variant | 4/4 | XP_006712039.1 | ||
FOSL2 | XM_006711977.4 | c.562C>T | p.Arg188Cys | missense_variant | 4/4 | XP_006712040.1 | ||
FOSL2 | XM_005264231.5 | c.*113C>T | 3_prime_UTR_variant | 5/5 | XP_005264288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOSL2 | ENST00000264716.9 | c.628C>T | p.Arg210Cys | missense_variant | 4/4 | 1 | NM_005253.4 | ENSP00000264716.4 | ||
FOSL2 | ENST00000379619.5 | c.604C>T | p.Arg202Cys | missense_variant | 4/4 | 1 | ENSP00000368939.1 | |||
FOSL2 | ENST00000436647.1 | c.511C>T | p.Arg171Cys | missense_variant | 4/4 | 2 | ENSP00000396497.1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151844Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
151844
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000165 AC: 4AN: 242182Hom.: 0 AF XY: 0.0000303 AC XY: 4AN XY: 131930
GnomAD3 exomes
AF:
AC:
4
AN:
242182
Hom.:
AF XY:
AC XY:
4
AN XY:
131930
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000303 AC: 44AN: 1454320Hom.: 0 Cov.: 33 AF XY: 0.0000318 AC XY: 23AN XY: 723618
GnomAD4 exome
AF:
AC:
44
AN:
1454320
Hom.:
Cov.:
33
AF XY:
AC XY:
23
AN XY:
723618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151844Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74146
GnomAD4 genome
AF:
AC:
14
AN:
151844
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2024 | The c.628C>T (p.R210C) alteration is located in exon 4 (coding exon 4) of the FOSL2 gene. This alteration results from a C to T substitution at nucleotide position 628, causing the arginine (R) at amino acid position 210 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;T;D
Polyphen
1.0
.;D;.
Vest4
MutPred
0.33
.;Loss of methylation at R210 (P = 0.0427);.;
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at